期刊
CELL ADHESION & MIGRATION
卷 8, 期 2, 页码 165-176出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cam.28495
关键词
PECAM-1; CXCR7; endothelial cell adhesion; invasion; cancer vascular dysfunction; ECIS
类别
资金
- National Cancer Institute [5R01CA099906-07]
- National Institutes of Health [8P510D011092-53, 5T32AI007472-17, U54CA143906]
- Medical Research Foundation Early Clinical Investigator Award
The homeostatic function of endothelial cells (EC) is critical for a number of physiological processes including vascular integrity, immunity, and wound healing. Indeed, vascular abnormalities resulting from EC dysfunction contribute to the development and spread of malignancies. The alternative SDF-1/CXCL12 receptor CXCR7 is frequently and specifically highly expressed in tumor-associated vessels. In this study, we investigate whether CXCR7 contributes to vascular dysfunction by specifically examining the effect of CXCR7 expression on EC barrier function and motility. We demonstrate that CXCR7 expression in EC results in redistribution of CD31/PECAM-1 and loss of contact inhibition. Moreover, CXCR7+ EC are deficient in barrier formation. We show that CXCR7-mediated motility has no influence on angiogenesis but contributes to another motile process, the invasion of CXCR7+ EC into ligand-rich niches. These results identify CXCR7 as a novel manipulator of EC barrier function via alteration of PECAM-1 homophilic junctions. As such, aberrant expression of CXCR7 in the vasculature has the potential to disrupt vascular homeostasis and could contribute to vascular dysfunction in cancer systems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据